🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12074+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12074 recruiting trials

Phase 2RecruitingNCT05843253

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

👨‍⚕️ Margot Lazow, MD, Nationwide Children's Hospital📍 21 sites📅 Started Aug 2024View details ↗
NAEnrolling by InvitationNCT05941559

EMDR for Persistent Pain in RA

🏥 Medisch Spectrum Twente📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06546631

Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients

🏥 University College Cork📍 1 site📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06535607

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

🏥 AstraZeneca📍 59 sites📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06185751

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

👨‍⚕️ Armin Ghobadi, M.D., Washington University School of Medicine📍 1 site📅 Started Aug 2024View details ↗
Phase 1RecruitingNCT06357182

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

👨‍⚕️ Curtis A Lachowiez, OHSU Knight Cancer Institute📍 1 site📅 Started Aug 2024View details ↗
NAEnrolling by InvitationNCT06863831

A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC

👨‍⚕️ Li Feng, Ph.D., Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06530849

A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus

🏥 Gracell Biotechnologies (Shanghai) Co., Ltd.📍 2 sites📅 Started Aug 2024View details ↗
Enrolling by InvitationNCT06712017

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

👨‍⚕️ Xiaobin Feng, MD, Beijing Tsinghua Changgeng Hospital📍 6 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06451861

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

👨‍⚕️ Jianyu Weng, Guangdong Provincial People Hosptial📍 13 sites📅 Started Aug 2024View details ↗
Phase 2RecruitingNCT06376526

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

👨‍⚕️ Dickran Kazandjian, MD, University of Miami📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06590467

Abbott Structural Heart Device Registry

👨‍⚕️ Ryan Palmer, Abbott📍 27 sites📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06290141

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

🏥 Sanofi📍 113 sites📅 Started Aug 2024View details ↗
RecruitingNCT06574295

HTA of NIVATS Based on RWE

👨‍⚕️ Yingyao Chen, PhD, School of Public Health,Fudan University📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06550063

HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes

👨‍⚕️ John V Reynolds, MBBCh,MD, Trinity St James Cancer Institute📍 1 site📅 Started Aug 2024View details ↗
Phase 1, PHASE2RecruitingNCT06574581

ADSCs Therapy in Patients With CTD-ILD

🏥 China Medical University Hospital📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06560840

Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV

👨‍⚕️ Hongzhou Lu, Dr, Shenzhen Third People's Hospital📍 1 site📅 Started Aug 2024View details ↗
NARecruitingNCT06629636

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

👨‍⚕️ Yoshiharu M., Yoshiharu Morimoto, MD, PhD, Sankaky Medical Corporation📍 1 site📅 Started Aug 2024View details ↗
EARLY_Phase 1RecruitingNCT06519565

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

👨‍⚕️ Heng Mei, Ph.D&M.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 2 sites📅 Started Aug 2024View details ↗
RecruitingNCT06439862

Study of the Quality of Life in School Aged-children With Posterior Urethral Valves

👨‍⚕️ BIDAULT Valeska, MD, Hospices Civils de Lyon📍 1 site📅 Started Aug 2024View details ↗
← PreviousPage 252 of 604Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →